& Dutta, D
In T2D, therapeutic options, such as dipeptidyl peptidase-4 (DPP-4) inhibitors, incretin-based drugs, and GLP-1 analogues, target -cell function, but not all patients are responsive and approximately 50% ultimately require daily insulin injections due to -cell exhaustion and death (149)
but also, it's something that people understand," Henry said
The therapeutic potential of GLP-1 receptor agonists first gained attention due to their ability to help individuals with type 2 diabetes maintain blood glucose levels
Some folks also dig alternative and complementary therapies like yoga, behavioral therapy, acupuncture, or massage therapy.
Antioxidant characteristics of L-histidine 11The work described in this manuscript was partially sponsored and funded by Cytos Pharmaceuticals, LLC